
pmid: 21816360
Erythropoietin, the red blood cell-making cytokine, is also a potential cytoprotective agent in heart disease. In this issue of Cell Stem Cell, Hoch et al. (2011) use two heart failure models, including chemotherapeutic cardiotoxicity, to reveal a mechanistic connection between reduced cardiomyocyte production of erythropoietin and neoangiogenesis by cardiac progenitors.
Heart Failure, Myocardium, Stem Cells, Endothelial Cells, Antineoplastic Agents, Cell Differentiation, Cell Biology, Genetics, Molecular Medicine, Animals, Humans, Erythropoietin
Heart Failure, Myocardium, Stem Cells, Endothelial Cells, Antineoplastic Agents, Cell Differentiation, Cell Biology, Genetics, Molecular Medicine, Animals, Humans, Erythropoietin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
